NNH — New Nordic Healthbrands AB Share Price
Last trade - 00:00- SEK122.66m
- SEK137.68m
- SEK533.85m
- 59
- 77
- 35
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.16 | ||
| Price to Tang. Book | 1.2 | ||
| Price to Free Cashflow | 4.91 | ||
| Price to Sales | 0.23 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.91% | ||
| Return on Equity | -5.67% | ||
| Operating Margin | -0.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 452.61 | 450.06 | 514.85 | 487.5 | 533.85 | n/a | n/a | 6.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +5.85 | -36.72 | +19.92 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
New Nordic Healthbrands AB (New Nordic) is a Sweden-based food supplement and naturopathy company. The Company develops and sells dietary supplements, herbal remedies and related personal care products. New Nordic offers products in such segments as Diet, which includes brand names Apple Cider, BioFirm and Chili Burn, among others; Vitality, which includes brands Blue Berry, Frutin, Active Liver and dida, among others, and Beauty, which includes product lines Hair Volume, Nail Strong and Skin Care, among others. New Nordic's products are available in more than 30 countries, with focus on the Nordic region and the United States.
Directors
- Marinus Blabjerg Soerensen CHM (65)
- Karl Bergman Jensen CEO (54)
- Ivan Ruscic CFO
- Ditte Bihorac COO
- Lennart Sjolund IND (70)
- Jessica Tyreman IND (47)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 3rd, 2006
- Public Since
- January 23rd, 2007
- No. of Employees
- 73
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 6,195,200
- Address
- The Point, Hyllie Boulevard 34, MALMO, 215 32
- Web
- https://newnordic.se/
- Phone
- +46 446236414
- Auditors
- Deloitte
Upcoming Events for NNH
Similar to NNH
AAK AB (publ)
OMX Nordic Exchange Stockholm
Agtira AB
OMX Nordic Exchange Stockholm
Aker Biomarine ASA
OMX Nordic Exchange Stockholm
Akva ASA
OMX Nordic Exchange Stockholm
Atlantic Sapphire ASA
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:15 UTC, shares in New Nordic Healthbrands AB are trading at SEK19.80. This share price information is delayed by 15 minutes.
Shares in New Nordic Healthbrands AB last closed at SEK19.80 and the price had moved by -28% over the past 365 days. In terms of relative price strength the New Nordic Healthbrands AB share price has underperformed the FTSE Global All Cap Index by -32.41% over the past year.
There is no consensus recommendation for this security.
New Nordic Healthbrands AB does not currently pay a dividend.
New Nordic Healthbrands AB does not currently pay a dividend.
New Nordic Healthbrands AB does not currently pay a dividend.
To buy shares in New Nordic Healthbrands AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK19.80, shares in New Nordic Healthbrands AB had a market capitalisation of SEK122.66m.
Here are the trading details for New Nordic Healthbrands AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: NNH
Based on an overall assessment of its quality, value and momentum New Nordic Healthbrands AB is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like New Nordic Healthbrands AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +10.41%.
As of the last closing price of SEK19.80, shares in New Nordic Healthbrands AB were trading -2.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The New Nordic Healthbrands AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK19.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
New Nordic Healthbrands AB's management team is headed by:
- Marinus Blabjerg Soerensen - CHM
- Karl Bergman Jensen - CEO
- Ivan Ruscic - CFO
- Ditte Bihorac - COO
- Lennart Sjolund - IND
- Jessica Tyreman - IND